Health care plastics supplier MGS Mfg. Group Inc. has acquired Denmark-based consulting and product development firm Technolution A/S.
"By combining forces, Technolution and MGS mitigate project risks for their clients and create an approach that streamlines the supply chain and accelerates time-to-market," a June 6 news release said.
"Extending our offerings into the early stages of product development takes us to the next level of medical contract manufacturing," MGS CEO Paul Manley said in the release.
"Having multiple providers is inefficient and costly for pharma and [medical technology] companies," Technolution CEO Thomas Bach Agerslev said. "That's why they increasingly demand end-to-end solutions from a single supplier such as Technolution and MGS. For customers, this means a more integrated process, smoother collaboration through all phases, and as a result, faster time-to-market."
"We're very excited by this opportunity for our company," Allan Spork, Technolution founder and primary shareholder, said. "MGS has already acquired Formteknik, a provider of valuable services from the DFM/ESI to the validated upscale turnkey solution, with whom we have been working closely for more than a decade. Bringing us all together makes our offering uniquely comprehensive."
A representative for MGS could not immediately respond to inquiry by Plastics News.
Germantown, Wis.-based MGS operates 16 locations globally in tooling, molding and automation for drug delivery devices, diagnostics and more.
Technolution, which provides guidance on research and development, regulatory compliance, quality and project management, is based in Hørsholm, north of Copenhagen. The company employs 77.